In this issue:
Efficacy and safety of rVIII-SingleChain in severe haemophilia A
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
FFP vs PCC versus in patients with ICH related to vitamin K antagonists
PE prevalence of among patients hospitalised for syncope
A rapid pro-haemostatic agent to reverse the effects of direct oral anticoagulants
Hyperfibrinolysis increases BBB permeability by a plasmin- and bradykinin-dependent mechanism
TM-dependent PC activation is required for mitochondrial function and myelination in the CNS
Rivaroxaban limits complement activation compared with warfarin in APS patients with VTE
D-dimer levels at incident VTE diagnosis and the risk of cancer
Hereditary risk factors for thrombophilia and probability of VTE during pregnancy and puerperium
Please login below to download this issue (PDF)